Skip to main content

Table 6 The number of common drugs and JI score for early- and late-stage using the enrichment score (ES) and cMap p-value (less than 0.1) for meta-analysis

From: Drug repositioning for non-small cell lung cancer by using machine learning algorithms and topological graph theory

  Effect size ES < 0 & p MA -value <0.1 ES < 0 & cMap p-value < 0.1
Effect size   Early-stage Late-stage Early-stage Late-stage
ES < 0 & p MA -value <0.1 Early-stage   0.557 0.078 0.152
Late-stage 39   0.074 0.194
ES < 0 & cMap p-value < 0.1 Early-stage 5 4   0.143
Late-stage 12 13 5